Jianke.com, a China-based smart healthcare service platform, has unveiled its financial report for the first half of 2024. The company recorded a modest year-on-year (YOY) increase in revenue, reaching RMB 1.323 billion, which is a 2.5% uptick. More impressively, the adjusted net profit saw a substantial surge of 395.0% YOY, amounting to RMB 15.055 million.
Breaking down the business segments, the online retail pharmacy service led the way with a 9.6% YOY increase to RMB 674 million, contributing to 50.9% of the total revenue. However, the comprehensive medical service revenue experienced a significant decline of 47.6% YOY, reaching RMB 321 million and making up 24.2% of the total revenue. The wholesale business segment reported a remarkable 842.1% YOY growth, with revenue of RMB 279 million, now accounting for 21.1% of the total. Additionally, the customized content and marketing solution services showed a healthy 42.3% YOY increase, generating RMB 49.381 million and representing 3.8% of the total revenue.
At the close of the reporting period, Jianke.com had amassed an impressive subscriber base of 45.6 million users. The number of physicians subscribed to its Home-to-Home (H2H) service platform has risen to 217,000, with a notable 59.3% hailing from Class 3A hospitals and 38.8% holding the prestigious title of associate chief physician or higher. The company has established partnerships with over 1,500 suppliers and more than 800 pharmaceutical companies, offering users an extensive range of 213,000 drug inventory units (SKUs), with prescription drugs constituting 61.7% of the total offerings.- Flcube.com
